Author:
Gibson David F. C.,Johnson Delinda A.,Goldstein David,Langan-Fahey Susan M.,Borden Ernest C.,Jordan V. Craig
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Jordan VC, Murphy CS: Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 11: 573?610, 1990
2. Breast Cancer Trials Committee, Scottish Trials Office (MRC), Edinburgh: Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet ii: 171?176, 1987
3. Baum M, and other members of the Nolvadex Adjuvant Trial Organization: Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. Lancet i: 836?840, 1985
4. EBCTCC: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 319: 1681?1691, 1988
5. Powles TJ, Hardy JR, Ashley SE, Farrington GM, Cosgrove D, Davey JB, Dowsett M, McKinna JA, Nash AG, Sinnett HD, Tillyer CR, Treleaven JG: A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 60: 126?131, 1989
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献